OVA (241-270)

OVA (241-270) is a 30-residue ovalbumin fragment used to explore extended antigenic regions beyond canonical SIINFEKL. Its sequence supports peptide–MHC binding and epitope-mapping studies. Researchers employ it to identify overlapping determinants in OVA immunology. The peptide aids structural dissection of antigen presentation.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: O05009

CAS No:2648610-97-1

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C154H246N34O51S1
M.W/Mr.
3421.9
Sequence
One Letter Code:SMLVLLPDEVSGLEQLESIINFEKLTEWTS
Length
30

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServicePeptide Nucleic Acids SynthesisPeptide Modification ServicesPeptide Synthesis ServicesPeptide CDMOCustom Conjugation ServicePeptide Analysis ServicesEpitope Mapping Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers